This document is an excerpt from the EUR-Lex website
Document 62020TA0397
Case T-397/20: Judgment of the General Court of 6 October 2021 — Allergan Holdings France v EUIPO — Dermavita Company (JUVEDERM) (EU trade mark — Revocation proceedings — EU word mark JUVEDERM — Genuine use of the mark — Use in connection with the goods in respect of which the mark is registered — Article 51(1)(a) of Regulation (EC) No 207/2009 (now Article 58(1)(a) of Regulation (EU) 2017/1001))
Case T-397/20: Judgment of the General Court of 6 October 2021 — Allergan Holdings France v EUIPO — Dermavita Company (JUVEDERM) (EU trade mark — Revocation proceedings — EU word mark JUVEDERM — Genuine use of the mark — Use in connection with the goods in respect of which the mark is registered — Article 51(1)(a) of Regulation (EC) No 207/2009 (now Article 58(1)(a) of Regulation (EU) 2017/1001))
Case T-397/20: Judgment of the General Court of 6 October 2021 — Allergan Holdings France v EUIPO — Dermavita Company (JUVEDERM) (EU trade mark — Revocation proceedings — EU word mark JUVEDERM — Genuine use of the mark — Use in connection with the goods in respect of which the mark is registered — Article 51(1)(a) of Regulation (EC) No 207/2009 (now Article 58(1)(a) of Regulation (EU) 2017/1001))
OJ C 481, 29.11.2021, pp. 24–25
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
29.11.2021 |
EN |
Official Journal of the European Union |
C 481/24 |
Judgment of the General Court of 6 October 2021 — Allergan Holdings France v EUIPO — Dermavita Company (JUVEDERM)
(Case T-397/20) (1)
(EU trade mark - Revocation proceedings - EU word mark JUVEDERM - Genuine use of the mark - Use in connection with the goods in respect of which the mark is registered - Article 51(1)(a) of Regulation (EC) No 207/2009 (now Article 58(1)(a) of Regulation (EU) 2017/1001))
(2021/C 481/34)
Language of the case: English
Parties
Applicant: Allergan Holdings France SAS (Courbevoie, France) (represented by: J. Day, Solicitor, and T. de Haan, lawyer)
Defendant: European Union Intellectual Property Office (represented by: K. Zajfert and V.J. Ruzek, acting as Agents)
Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Dermavita Company S.a.r.l. (Beirut, Lebanon) (represented by: D. Todorov, lawyer)
Re:
Action brought against the decision of the Fourth Board of Appeal of EUIPO of 14 April 2020 (Case R 877/2019-4), relating to revocation proceedings between Dermavita Company and Allergan Holdings France.
Operative part of the judgment
The Court:
|
1. |
Rejects the plea of inadmissibility; |
|
2. |
Dismisses the action; |
|
3. |
Orders Allergan Holdings France SAS to bear, in addition to its own costs, the costs incurred by the European Union Intellectual Property Office (EUIPO) and two-thirds of the costs incurred by Dermavita Company S.a.r.l. relating to the present proceedings; |
|
4. |
Orders Dermavita Company S.a.r.l. to bear a third of its own costs relating to the present proceedings. |